{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:07:46Z","timestamp":1789013266044,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.yebeh.2026.111246","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:48:55Z","timestamp":1785912535000},"page":"111246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Risk of cutaneous adverse reactions to lamotrigine and levetiracetam by age, sex, and reproductive status"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0055-7498","authenticated-orcid":false,"given":"Takafumi","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5879-155X","authenticated-orcid":false,"given":"Shuichiro","family":"Neshige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narumi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3589-0215","authenticated-orcid":false,"given":"Keito","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riho","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6234-1236","authenticated-orcid":false,"given":"Koji","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7613-8717","authenticated-orcid":false,"given":"Hirofumi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2026.111246_b0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.seizure.2019.07.015","article-title":"Rashes and other hypersensitivity reactions associated with antiepileptic drugs: a review of current literature","volume":"71","author":"Mani","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2026.111246_b0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2019.07.003","article-title":"Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting","volume":"72","author":"Fowler","year":"2019","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.yebeh.2026.111246_b0015","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1528-1167.2007.01109.x","article-title":"Rash from antiepileptic drugs: influence by gender, age, and learning disability","volume":"48","author":"Alvestad","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111246_b0020","doi-asserted-by":"crossref","unstructured":"Hirsch LJ, Weintraub DB, Buchsbaum R, et al. Predictors of Lamotrigine-associated rash. Epilepsia 2006;47(2):318-22. (In eng). DOI: 10.1111\/j.1528-1167.2006.00423.x.","DOI":"10.1111\/j.1528-1167.2006.00423.x"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111246_b0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"The EuroSCAR-study J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.yebeh.2026.111246_b0030","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics","volume":"64","author":"Mockenhaupt","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.yebeh.2026.111246_b0035","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/epi.17563","article-title":"Effects of dosage in new users of lamotrigine inducing epidermal necrolysis: results of the German registry of severe skin reactions","volume":"64","author":"Diederich","year":"2023","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.yebeh.2026.111246_b0040","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jamaneurol.2018.0278","article-title":"Association of HLA-A*31:01 screening with the incidence of carbamazepine-induced cutaneous adverse reactions in a Japanese population","volume":"75","author":"Mushiroda","year":"2018","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.yebeh.2026.111246_b0045","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/jcph.2289","article-title":"Carbamazepine-induced severe cutaneous adverse drug reactions: a 21-year comparison between children and adults in Malaysia","volume":"63","author":"Hariraj","year":"2023","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.yebeh.2026.111246_b0050","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2026.111246_b0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.seizure.2018.06.024","article-title":"Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in Asian populations: a meta-analysis","volume":"60","author":"Deng","year":"2018","journal-title":"Seizure"},{"issue":"11","key":"10.1016\/j.yebeh.2026.111246_b0060","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/009127009803801103","article-title":"Gender differences in adverse drug reactions","volume":"38","author":"Tran","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2026.111246_b0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.seizure.2020.01.002","article-title":"Levetiracetam and cutaneous adverse reactions: a systematic review of descriptive studies","volume":"75","author":"Rashid","year":"2020","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.yebeh.2026.111246_b0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2188\/jea.JE20090066","article-title":"Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage","volume":"20","author":"Kimura","year":"2010","journal-title":"J Epidemiol"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111246_b0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1248\/bpb.b14-00543","article-title":"The accuracy of Japanese claims data in identifying breast cancer cases","volume":"38","author":"Sato","year":"2015","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111246_b0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in stevens-johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.yebeh.2026.111246_b0085","first-page":"1041","article-title":"Inferring ADR causality by predicting the naranjo score from clinical notes","volume":"25","author":"Rawat","year":"2021","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.yebeh.2026.111246_b0090","unstructured":"Association JD. Clinical Practice Guidelines for Drug-induced Hypersensitivity Syndrome 2023 [in Japanese]. Tokyo: 2023. (https:\/\/www.dermatol.or.jp\/modules\/guideline\/index.php?content_id=2)."},{"key":"10.1016\/j.yebeh.2026.111246_b0095","unstructured":"Association JD. Clinical Practice Guidelines for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis [in Japanese]. Tokyo: 2016. (https:\/\/www.dermatol.or.jp\/modules\/guideline\/index.php?content_id=2)."},{"issue":"11","key":"10.1016\/j.yebeh.2026.111246_b0100","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4088\/JCP.v63n1110","article-title":"Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management","volume":"63","author":"Calabrese","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.yebeh.2026.111246_b0105","unstructured":"Sharma A., Nagalli S. Chronic Liver Disease. In: StatPearls [Internet]. Treasure Island (FL). StatPearls Publishing; 2023."},{"issue":"13","key":"10.1016\/j.yebeh.2026.111246_b0110","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"J Am Med Assoc"},{"issue":"7","key":"10.1016\/j.yebeh.2026.111246_b0115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jamda.2015.02.004","article-title":"Global prevalence of physical frailty by fried's criteria in community-dwelling elderly with national population-based surveys","volume":"16","author":"Choi","year":"2015","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"10.1016\/j.yebeh.2026.111246_b0120","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002280000146","article-title":"Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects","volume":"56","author":"Ebert","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.yebeh.2026.111246_b0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clpt.2006.04.014","article-title":"Lopinavir\/ritonavir reduces lamotrigine plasma concentrations in healthy subjects","volume":"80","author":"van der Lee","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.yebeh.2026.111246_b0130","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/cns.13796","article-title":"Pharmacokinetic changes for newer antiepileptic drugs and seizure control during pregnancy","volume":"28","author":"Yin","year":"2022","journal-title":"CNS Neurosci Ther"},{"issue":"19","key":"10.1016\/j.yebeh.2026.111246_b0135","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1212\/01.wnl.0000334295.50403.4c","article-title":"Cross-sensitivity of skin rashes with antiepileptic drug use","volume":"71","author":"Hirsch","year":"2008","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.yebeh.2026.111246_b0140","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/01.wnl.0000261917.83337.db","article-title":"Comparison and predictors of rash associated with 15 antiepileptic drugs","volume":"68","author":"Arif","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111246_b0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-0690(03)00032-6","article-title":"Drug eruptions and other adverse drug effects in aged skin","volume":"18","author":"Sullivan","year":"2002","journal-title":"Clin Geriatr Med"},{"issue":"6","key":"10.1016\/j.yebeh.2026.111246_b0150","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1136\/bmjopen-2015-007711","article-title":"Safety of lamotrigine in paediatrics: a systematic review","volume":"5","author":"Egunsola","year":"2015","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.yebeh.2026.111246_b0155","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1345\/aph.18422","article-title":"Factors influencing the incidence of lamotrigine-related skin rash","volume":"33","author":"Wong","year":"1999","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1016\/j.yebeh.2026.111246_b0160","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/CM9.0000000000003114","article-title":"Role of maternal-fetal immune tolerance in the establishment and maintenance of pregnancy","volume":"137","author":"Wang","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.yebeh.2026.111246_b0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2020.07.013","article-title":"Immunology and the immunological response in pregnancy","volume":"76","author":"Orefice","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026003677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026003677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:25:42Z","timestamp":1789010742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026003677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S1525505026003677"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111246","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of cutaneous adverse reactions to lamotrigine and levetiracetam by age, sex, and reproductive status","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111246"}}